Health Condition 1: null- Pregnant women who are between 18 to 40 years age are considered for this study. For baseline samples, non-pregnant women will also be considered.
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Pregnant Women inclusion criteria: 18 to 40 years of age Non-pregnant women inclusion criteria (for baseline samples): 18 to 40 years of age
Exclusion criteria
Exclusion criteria: Pregnant women exclusion criteria: those who are already on psychotropic medication. Non-pregnant women exclusion criteria (for baseline samples): those who are already on psychotropic medication and those who have a baby of less than 2 years old.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To monitor depression in pregnant women using point-of-care device. Achieve biomarker validation / discovery with the use of metabolomics.Timepoint: Samples from the pregant women are collected twice before the delivery (one between 24-28 weeks and one during 36-38 weeks of gestational period) and four times after deliver, i.e., 1st day, 7th day, 14th day and 3 months after delivery. The baseline sample collection from the non-pregnant women participants will be taken only once. | — |
Secondary
| Measure | Time frame |
|---|---|
| Facilitate the early diagnosis and management of depression in pregnant women and mothers. Timepoint: 3 years | — |
Countries
India
Contacts
Sri Sathya Sai Institute of Higher Learning